Israel’s LifeSeal, the no-leak sealant solution for patients who have undergone gastrointestinal (GI) surgery (see Aug 16), has received CE approval for use in the European Union.  LifeSeal has also been fast-tracked for approval by the US FDA through its … Continue reading →

The US Food and Drugs Administration has given approval for Evarrest – a biological sealant for stopping problematic bleeding during surgery. Evarrest is produced in Israel by Omrix Biopharmaceuticals – a division of US giant Johnson & Johnson. http://www.globes.co.il/serveen/globes/docview.asp?did=1000806563&fid=1725

Israel’s Vigor Medical Technologies won the Innovex Disrupt contest at Tel Aviv’s Innovex2016 conference. Vigor’s sealant system treats thoracic trauma, a chest injury that can cause the lungs to collapse. If treated within one hour, the patient has an 80% … Continue reading →

Israel’s LifeBond has developed LifeSeal (see Aug 2011 newsletter) – a sealant to greatly reduce surgical leaks, which are associated with potential infections and other serious complications, risking the lives of hundreds of thousands every year. LifeBond has just raised … Continue reading →

Surgeons will be pleased to be able to seal up vascular operations using Seal-V from Israel’s Sealantis. A spin-off from Israel’s Technion, Seal-V is safer than protein based or synthetic based alternatives. It is highly effective, fast bonding, easy to … Continue reading →

Johnson & Johnson has invested in Israeli bio-med start-up Lifebond that is developing a surgical sealant apparently superior to the one that J&J already owns the rights to. http://www.globes.co.il/serveen/globes/docview.asp?did=1000671782&fid=1725